Observing the effects of antiretroviral therapy in HIV/AIDS patients
Observational Study of Antiretroviral Therapy Cohort in Patients With HIV/AIDS
This study is trying to see how well antiretroviral therapy works for people with HIV/AIDS and what side effects they might experience over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 15000 (estimated) |
| Ages | 14 Years and up |
| Sex | All |
| Sponsor | Guangzhou 8th People's Hospital Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT04667026 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a follow-up cohort of patients with HIV/AIDS undergoing antiretroviral therapy (ART). Participants will be monitored at various intervals—before treatment and at 1, 2, and 3 months after treatment, as well as every 3 months thereafter—to assess ART efficacy, adverse reactions, and complications. The study will also investigate mortality rates and causes of death among these patients, providing valuable data to enhance ART effectiveness and improve patient quality of life.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 14 and older who have been diagnosed with HIV and are currently receiving antiretroviral therapy.
Not a fit: Patients who are younger than 14 years old will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved ART strategies and better health outcomes for patients living with HIV/AIDS.
How similar studies have performed: Other observational studies on ART have shown success in improving treatment protocols and patient outcomes, indicating that this approach is supported by prior research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients has a history of diagnosis of HIV. * Receiving antiretroviral therapy. * Good treatment compliance. Exclusion Criteria: * Aged less than 14 years of old.
Where this trial is running
Guangzhou, Guangdong
- Guangzhou Eighth People's Hospital — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Principal investigator: Ling-Hua Li, doctor — Guangzhou Eighth People's Hospital
- Study coordinator: Linghua Li, MD,PhD
- Email: llheliza@126.com
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.